 | G1 Therapeutics' (GTHX) CEO Mark Velleca on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 1:57 AM |
| G1 Therapeutics EPS in-line, misses on revenue
seekingalpha.com - August 5 at 8:57 PM |
 | G1 Therapeutics Provides Second Quarter 2020 Corporate and Financial Update
finance.yahoo.com - August 5 at 8:57 PM |
| G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August 2020
finance.yahoo.com - August 4 at 8:35 AM |
 | G1 Therapeutics' (GTHX) Buy Rating Reaffirmed at Needham & Company LLC
americanbankingnews.com - August 4 at 6:14 AM |
| G1 Therapeutics inks trilaciclib pact with Simcere in Greater China
seekingalpha.com - August 3 at 5:31 PM |
| HC Wainwright Reiterates Buy Rating for G1 Therapeutics (NASDAQ:GTHX)
www.americanbankingnews.com - August 3 at 12:01 PM |
| G1 Therapeutics and Simcere Announce Exclusive License Agreement for Trilaciclib in Greater China
finance.yahoo.com - August 3 at 7:28 AM |
| G1 Therapeutics Inc (NASDAQ:GTHX) Sees Large Increase in Short Interest
www.americanbankingnews.com - August 1 at 9:46 PM |
| G1 Therapeutics (GTHX) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 30 at 10:25 AM |
|
| G1 Therapeutics to Provide Second Quarter 2020 Corporate and Financial Update on August 5, 2020
finance.yahoo.com - July 29 at 8:20 AM |
| G1 Therapeutics (NASDAQ:GTHX) Stock Price Down 7.5%
www.americanbankingnews.com - July 28 at 9:01 PM |
| Wedbush Research Analysts Lift Earnings Estimates for G1 Therapeutics Inc (NASDAQ:GTHX)
www.americanbankingnews.com - July 27 at 1:10 AM |
| G1 Therapeutics Inc (NASDAQ:GTHX) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 26 at 5:10 AM |
| G1 Therapeutics inks lerociclib deal with EQRx
seekingalpha.com - July 23 at 6:04 AM |
| G1 Therapeutics Announces License Agreement for Lerociclib
finance.yahoo.com - July 22 at 6:08 PM |
| Analysts Expect G1 Therapeutics Inc (NASDAQ:GTHX) to Post -$0.85 EPS
www.americanbankingnews.com - July 16 at 4:25 PM |
| G1 Therapeutics inks trilaciclib promotion deal with Boehringer Ingelheim
seekingalpha.com - July 1 at 7:15 PM |
| G1 Therapeutics and Boehringer Ingelheim Announce Co-Promotion Agreement for Trilaciclib in Small Cell Lung Cancer in the United States and Puerto Rico
finance.yahoo.com - June 30 at 5:20 PM |
| Were Hedge Funds Right About Betting On G1 Therapeutics, Inc. (GTHX)?
finance.yahoo.com - June 30 at 5:20 PM |
| G1 Therapeutics Has Multiple Roadmaps To A Multi-Billion Dollar Market Cap
seekingalpha.com - June 24 at 6:24 PM |
 | RTP firm inks potential $46 million deal for cancer treatment in Asia
www.bizjournals.com - June 22 at 6:41 PM |
| G1 Therapeutics inks lerociclib deal with Genor Biopharma
seekingalpha.com - June 22 at 8:39 AM |
| G1 Therapeutics and Genor Biopharma Announce Exclusive License Agreement for Lerociclib in Asia-Pacific Region
finance.yahoo.com - June 22 at 8:39 AM |
| How G1 Therapeutics (GTHX) Stock Stands Out in a Strong Industry
finance.yahoo.com - June 11 at 10:00 AM |
| G1 Therapeutics secures $100M in debt financing
seekingalpha.com - June 1 at 7:50 PM |
| G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital
finance.yahoo.com - June 1 at 7:50 PM |
 | GTHX G1 Therapeutics, Inc. Common Stock
www.nasdaq.com - May 22 at 11:31 PM |
| G1 Therapeutics to Present Data Showing Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer at the ASCO20 Virtual Scientific Program
finance.yahoo.com - May 13 at 6:08 PM |
| G1 Therapeutics, Inc. (GTHX) CEO Mark Velleca on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 4:55 PM |
|
| G1 Therapeutics, Inc. (GTHX) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 7 at 3:14 PM |
| G1 Therapeutics EPS beats by $0.16
seekingalpha.com - May 7 at 4:28 AM |
| G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update
finance.yahoo.com - May 7 at 4:28 AM |
| We Think G1 Therapeutics (NASDAQ:GTHX) Can Afford To Drive Business Growth
finance.yahoo.com - May 6 at 8:02 AM |
| G1 Therapeutics to Provide First Quarter 2020 Corporate and Financial Update on May 6, 2020
finance.yahoo.com - April 29 at 10:30 AM |
| G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020
finance.yahoo.com - April 7 at 6:02 PM |
| Cover Story: Triangle life sciences gasping for capital, leaders
finance.yahoo.com - March 13 at 8:15 AM |
| G1 Therapeutics Announces Appointment of New Board Member and Chief Commercial Officer
finance.yahoo.com - March 12 at 9:28 AM |
| G1 Therapeutics EPS beats by $0.02
seekingalpha.com - February 26 at 6:24 PM |
| G1 Therapeutics Provides Fourth Quarter and Full-Year 2019 Corporate and Financial Update
finance.yahoo.com - February 26 at 6:24 PM |
| G1 Therapeutics to Present at Investor Conferences in March 2020
finance.yahoo.com - February 24 at 9:18 AM |
| G1 Therapeutics to Provide Fourth Quarter and Full Year 2019 Corporate and Financial Update on February 26, 2020
finance.yahoo.com - February 19 at 7:34 AM |
 | G1 Therapeutics to Participate in BTIG Targeted...
www.benzinga.com - February 17 at 9:26 AM |
 | G1 Therapeutics Presents Updated Data from Phase 1b/2a Trial of Oral CDK4/6 Inhibitor Lerociclib at 2019 San Antonio Breast
www.bloomberg.com - February 11 at 6:35 PM |
| G1 Therapeutics to Participate in Guggenheim...
www.benzinga.com - February 6 at 8:27 AM |
| G1 Therapeutics to Participate in Guggenheim Health Talks: Oncology Day on February 13, 2020
finance.yahoo.com - February 6 at 8:27 AM |
| Quantum Leap Healthcare Collaborative and G1 Therapeutics Announce the Selection of Trilaciclib in the I-SPY 2 TRIAL for Breast Cancer
finance.yahoo.com - January 14 at 7:55 AM |
| G1 Therapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 7:18 AM |
 | BRIEF-G1 Therapeutics Presents Data From Phase 1B/2A Trial Of Lerociclib At 2019 San Antonio Breast Cancer Symposium
www.msn.com - December 12 at 10:12 PM |
| G1 Therapeutics Presents Updated Data from Phase 1b/2a Trial of Oral CDK4/6 Inhibitor Lerociclib at 2019 San Antonio Breast Cancer Symposium (SABCS)
finance.yahoo.com - December 11 at 7:14 PM |
